ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

rzstudio / shutterstock.com

Prescribing Hope: The Placebo Effect Endures

Philip Seo, MD, MHS  |  June 21, 2018

“Wait. I can explain.” One could imagine this phrase coming up under many conditions in daily life. When I first became a physician, however, I would never have expected to use this phrase in my clinic. In medical school, I was taught the importance of dialogue in establishing a relationship with a patient. Statistics indicate…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:patient communicationpatient managementplacebo

Creative Online Strategies for Rheumatologists to Track & Assess Emerging Clinical Trial Data

Carina Stanton  |  June 20, 2018

With extensive clinical trial data being published daily, how does a rheumatologist stay up to date on latest breakthroughs? Rheumatologists can leverage multiple online resources to stay informed and apply information to patient care…

Filed under:Education & TrainingProfessional Topics Tagged with:clinical trialsdataEducationonlineonline education

EHRs Play a Role in Physician Burnout

Lara C. Pullen, PhD  |  June 20, 2018

A recently published research review notes physician burnout has become a crisis in the U.S. The authors describe how the added administrative tasks of electronic health records (EHRs) have contributed to the crisis, as well as how regulatory requirements and EHR platform design exacerbate the situation…

Filed under:Professional Topics Tagged with:electronic health record (EHR)Medical Recordsphysician burnoutTechnology

Fed Up with Rising Costs, Big U.S. Firms Dig Into Healthcare

Caroline Humer  |  June 12, 2018

SAN JOSE, Calif., (Reuters)—At its Silicon Valley headquarters, network gear maker Cisco Systems Inc. is going to unusual lengths to take control of the relentless increase in its U.S. healthcare costs. The company is among a handful of large American employers who are getting more deeply involved in managing their workers’ health instead of looking…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Cisco Systems Inc.Healthcarehealthcare cost

ACR/ARHP Visits the Hill; Drug Pricing ‘Blueprint’ Revealed

Angus Worthing  |  June 8, 2018

Greetings, Advocates! In my last update, I described the great news from February’s budget agreement that fixed Medicare’s payment adjustments so MIPS penalties would not include Part B drug costs, ensuring stabilization of the Medicare Part B drug system, among other successes. (Read the ACR’s press release on this topic.) I also described the Trump administration’s…

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:Association of Rheumatology Professionals (ARP)Biosimilarsdrug pricesfly-inWashington D.C. update

Think Globally; Act Locally: A Conversation with Luke Barré, MD, MPH

Carina Stanton  |  June 7, 2018

The ACR’s ability to address the big picture of rheumatologic care while focusing on individual practice and patient needs is one of the many things that attracted Luke Barré, MD, MPH, to the College early in his career. With training in both preventive medicine and rheumatology, Dr. Barré believes combined global and local views are…

Filed under:Profiles Tagged with:Communications and Marketing Committee (CMC)Luke Barré

ACR’s Affiliate Society Council Reports Solid Gains in Advocacy Efforts

Gretchen Henkel  |  June 7, 2018

It’s May, and soon, most state legislatures will be adjourning for the remainder of the year. Joseph Cantrell, JD, senior manager of state affairs for the ACR, who tracks the progress of state and federal patient care legislation, reports that several states saw solid gains during 2018 state sessions, which typically run from January to…

Filed under:Legislation & Advocacy Tagged with:Affiliate Society Council (ASC)Joseph Cantrellpharmacy benefit managers (PBMs)state legislation

Joint Efforts: RheumPAC Facilitates Progress

From the College  |  June 7, 2018

Advocacy and RheumPAC staff from the ACR and other medical specialty organizations gathered in Nashville this month to discuss the importance of making sure your members know the details of the work advocacy and the PAC are doing. Thus far, the ACR has had a very successful year in terms of its advocacy efforts. Following…

Filed under:From the CollegeLegislation & Advocacy Tagged with:ACR advocacyLeadership CirclePlatinum ClubRheumPACRheumPAC investors

Insight into the Downregulation of NK Cells in SLE Patients

Lara C. Pullen, PhD  |  June 4, 2018

New research suggests the downregulation of CD3ζ contributes to the altered function of NK cells in SLE patients, which may contribute to the increased risk of viral infections in these patients…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:SLEsystemic lupus erythematosus (SLE)

Current Graduate Medical Education Can’t Meet Future Needs

Arthritis & Rheumatology  |  June 1, 2018

In 2005, an ACR Workforce Study estimated the adult rheumatology workforce to be 4,946 providers and projected growth of only 1.2% by 2025, resulting in a projected deficit of 2,576 rheumatologists considering the estimated need. According to the 2015 Workforce Study, between 2005 and 2015, the percentage of internal medicine residents entering rheumatology has remained…

Filed under:Education & TrainingProfessional TopicsWorkforce Tagged with:ACR Workforce Studygraduate medical educationgraduate medical education (GME) fundingWorkforce Study

  • « Previous Page
  • 1
  • …
  • 173
  • 174
  • 175
  • 176
  • 177
  • …
  • 333
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences